Role of COX-1- and COX-2-synthesized prostaglandins in a rat model of arthritic pain

Drug Development Research

Volumn 51, Issue 4, 2000, Pages 253-259

  Martínez, Rosa Ventura ^a   Díaz, M Irene ^a   Patricia Hernandez G ^a   Ramírez, Adriana M Domínguez ^b   Salazar, Luis A ^a   Cabré, Francesc ^c   López Muñoz, Francisco J ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^c Laboratorios Menarini SA   (Spain)

Author keywords

Cyclooxygenase; Inflammatory pain; Nociception; PIFIR model; Prostaglandins

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; ROFECOXIB; URIC ACID;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTHRITIS; ARTICLE; CHRONIC PAIN; COMPUTER SYSTEM; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GOUT; HINDLIMB; HOMEOSTASIS; NONHUMAN; PROSTAGLANDIN SYNTHESIS; RAT;

EID: 0034474887     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.6     Document Type: Article

References (11)

1. Aguirre-Banuelos P, Castañeda-Hernández G, López-Munoz FJ, Granados-Soto V. 1999. Effect of coadministration of caffeine and either adenosine agonists or cyclic nucleotides on ketorolac analgesia. Eur J Pharmacol 377:175-182.
2. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. 1996. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672-2679.
3. Fort J. 1999. Celecoxib, a COX-2-specific inhibitor: the clinical data. Am J Orthop 28(Suppl. 3):13-18.
4. Furst DE. 1988. Comments on possible long-term consequences of nonsteroidal anti-inflammatory use. J Clin Pharmacol 28:550-553.
5. Gilroy DW, Tomlinson A, Willoughby DA. 1998. Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. Eur J Pharmacol 21;355:211-217.
6. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. 1999. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5:698-701.
7. Granados-Soto V, López-Munoz FJ, Castaneda-Hemández G, Salazar LA, Villareal JE, Flores-Murrieta FJ. 1993. Characterization of the analgesic effects of paracetamol and caffeine combinations in the pain-induced functional impairment model in the rat. J Pharm Pharmacol 45:627-631.
8. Granados-Soto V, Flores-Murrieta FJ, Castaneda-Hernández G, López-Munoz FJ. 1995. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac. Eur J Pharmacol 277:281-284.
9. Hawkey CJ. 1999. COX-2 inhibitors. Lancet 353:307-314.
10. Hoyo-Vadillo C, Pérez-Urizar J, López-Munoz FJ. 1995. Usefulness of the pain-induced functional impairment model to relate plasma levels of analgesic to their efficacy in rats. J Pharm Pharmacol 47:462465.
11. Jouzeau JY, Terlain B, Abid A, Nédélec E, Netter P. 1997. Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Drugs 53:563-582.